BTSG 📈 BrightSpring Health - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
BTSG: Home Healthcare, Pharmacy Services, Clinical Care
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky. Web URL: https://www.brightspringhealth.com
Additional Sources for BTSG Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BTSG Stock Overview
| Market Cap in USD | 2,967m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2024-01-26 |
BTSG Stock Ratings
| Growth 5y | 73.9% |
| Fundamental | 8.77% |
| Dividend | - |
| Rel. Strength Industry | 27318 |
| Analysts | 4.62/5 |
| Fair Price Momentum | 18.83 USD |
| Fair Price DCF | 20.39 USD |
BTSG Dividends
No Dividends PaidBTSG Growth Ratios
| Growth Correlation 3m | 73.6% |
| Growth Correlation 12m | 90.1% |
| Growth Correlation 5y | 90.1% |
| CAGR 5y | 57.00% |
| CAGR/Mean DD 5y | 9.62 |
| Sharpe Ratio 12m | 1.22 |
| Alpha | 36.35 |
| Beta | 0.75 |
| Volatility | 63.82% |
| Current Volume | 1409.3k |
| Average Volume 20d | 1549.4k |
What is the price of BTSG stocks?
As of December 22, 2024, the stock is trading at USD 17.27 with a total of 1,409,300 shares traded.
Over the past week, the price has changed by -6.95%, over one month by -8.09%, over three months by +17.24% and over the past year by +57.00%.
As of December 22, 2024, the stock is trading at USD 17.27 with a total of 1,409,300 shares traded.
Over the past week, the price has changed by -6.95%, over one month by -8.09%, over three months by +17.24% and over the past year by +57.00%.
Is BrightSpring Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, BrightSpring Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.77 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BTSG as of December 2024 is 18.83. This means that BTSG is currently overvalued and has a potential downside of 9.03%.
Neither. Based on ValueRay Fundamental Analyses, BrightSpring Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.77 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BTSG as of December 2024 is 18.83. This means that BTSG is currently overvalued and has a potential downside of 9.03%.
Is BTSG a buy, sell or hold?
BrightSpring Health has received a consensus analysts rating of 4.62. Therefor, it is recommend to buy BTSG.
BrightSpring Health has received a consensus analysts rating of 4.62. Therefor, it is recommend to buy BTSG.
- Strong Buy: 9
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for BTSG stock price target?
According to ValueRays Forecast Model, BTSG BrightSpring Health will be worth about 20.3 in December 2025. The stock is currently trading at 17.27. This means that the stock has a potential upside of +17.72%.
According to ValueRays Forecast Model, BTSG BrightSpring Health will be worth about 20.3 in December 2025. The stock is currently trading at 17.27. This means that the stock has a potential upside of +17.72%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 22 | 27.4% |
| Analysts Target Price | 15.7 | -9.2% |
| ValueRay Target Price | 20.3 | 17.7% |